Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.

placebo treatment, although this did not reach statistical significance (11.43 ± 0.97 vs. 9.96 ± 0.96 μmol/min/100 g, mean difference in paired sample t-test = −1.47, 95% CI: −3.09–0.15; p = 0.072, Cohen’s d = −0.575; Fig. 1a, b ).

also in 111,027 other papers